Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease

Kirbas S., Kirbas A., Tufekci A., Cure M. C., Cakmak S., Yazici T., ...More

ACTA CLINICA BELGICA, vol.71, no.2, pp.71-75, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 71 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.1080/17843286.2016.1138592
  • Journal Name: ACTA CLINICA BELGICA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.71-75
  • Keywords: Asymmetric dimethylarginine, Nitric oxide, Homocysteine, Parkinson's disease, ENDOTHELIAL DYSFUNCTION, HYPERHOMOCYSTEINAEMIA, METABOLISM, LINK
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Objectives: Endothelial dysfunction has been implicated as a crucial event in the development of several neurodegenerative diseases. The aim of this study was to investigate the serum homocysteine, asymmetric dimethylarginine (ADMA) and nitric oxide (NO) levels in patients with Parkinson's disease (PD) and to compare the results with data from healthy controls.